AnaSpec Inc.

AnaSpec, Eurogentec Group and In Vitro have announced a non-exclusive distributor agreement that will allow In Vitro

AnaSpec, Eurogentec Group, is pleased to offer two recombinant proteins for use in Neurodegenerative Disease Research, α-synuclein (SNCA) and β-synuclein (SNCB). Both α-synuclein and β-synuclein are expressed and purified from E. coli.

Expanding on our offerings of long wavelength, highly sensitive SIRT assays, AnaSpec, Eurogentec Group, is pleased to release 2 assay kits for SIRT2, the SensoLyte® 520 FRET SIRT2 Assay Kit and the SensoLyte® Green SIRT2 Assay Kit.

AnaSpec, Eurogentec Group, is pleased to announce the release of the industry's first fluorimetric kits for Cathepsin G, the SensoLyte® 520 Cathepsin G Assay Kit and SensoLyte® Rh110 Cathepsin G Assay Kit.

AnaSpec, Eurogentec Group, is pleased to highlight our wide collection of Fmoc- and Boc-protected PEGylated amino acids for PEGylated peptides synthesis.

AnaSpec, Eurogentec Group is pleased to introduce the SensoLyte® Green Elastase Assay Kit - the first FRET-based Elastase activity assay kit in the industry.

AnaSpec is pleased to expand our GFP antibodies offerings. The new GFP antibodies include two monoclonals raised in mouse and a third, a polyclonal raised in chicken.

AnaSpec, Eurogentec Group is pleased to highlight our Double-Dye Oligo Synthesis Service.

AnaSpec, Eurogentec Group is pleased to announce the expansion of our NS3/4A protease selection to include proteases from genotypes 1a, 1b, 2a, 3a and 4d.

AnaSpec, Eurogentec Group is pleased to offer anti-5-methylcytidine (Clone 33D3), Eurogentec’s most popular monoclonal antibody, for use in epigenetics research.